The WIRB-Copernicus Group, the world's largest provider of regulatory and ethical review services for human research, has partnered with Mytrus, a clinical technology and services company, to deliver a unique electronic informed consent solution that will help to streamline and enrich the clinical research process.

The WIRB-Copernicus Group will be Mytrus' exclusive independent Institutional Review Boards (IRB) partner, providing Mytrus' interactive e-consent as part of its comprehensive ethical oversight solution.

"The WIRB-Copernicus Group's partnership with Mytrus is in perfect alignment with our core values and vision for the industry," said Donald A. Deieso, Ph.D., executive chairman of the WIRB-Copernicus Group. "Mytrus' technology solution brings unmatched insight and integrity to the consent process, ensuring that patients are properly informed and enabling sponsors to attain meaningful data regarding patient consent and trial enrollment. We are proud to support Mytrus in its mission to Reinvent Consent, and we are delighted to add the Mytrus e-consent application to our growing suite of ethical review solutions."

Accessible via iPad, the Mytrus internet-based application digitizes and deepens the traditionally paper-based process of obtaining patient consent for participation in clinical trials, increasing efficiency and reducing study start-up time for contract research organizations and trial sponsors. The Mytrus tool uses video, voice instruction and quizzes to maximize patient interaction, which leads to improved comprehension and retention, enabling patients to make more informed decisions regarding their participation and care. The Mytrus e-consent solution has been translated into many languages, and has been proven most successful in the management of clinical trials involving a diverse subject population. In addition to providing a rich user experience for patients, the Mytrus solution generates advanced metrics and aggregate data to optimize the practice of clinical trial management for sponsors and CRO's.

"The WIRB-Copernicus Group is recognized as a global leader, and clinical research companies look to them to provide cutting-edge solutions that dramatically impact the cost and efficiency of clinical trials," said Anthony Costello, CEO of Mytrus. "We are pleased that the WIRB-Copernicus Group has recognized the innovation of our technology and has chosen to offer our e-consent application in its comprehensive suite of research oversight solutions."

The WIRB-Copernicus Group includes Western Institutional Review Board (WIRB), Copernicus Group IRB and IRBNet, a research compliance software solution serving institutions. The WIRB-Copernicus Group is the only ethical solutions provider capable of meeting the unique needs of institutions while supporting the speed and efficiency required by industry sponsors and CROs. With a comprehensive, streamlined review service that now includes Mytrus' e-consent, and a network of clients numbering in the thousands, the WIRB-Copernicus Group connects the world's leading sponsors and CROs with experienced research institutions to deliver new therapies and treatments to market with the highest degree of efficiency, quality and integrity.